Paradigm Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,400
| Closed | -$39K | – | 415 |
|
|
2017
Q2 | $39K | Sell |
1,400
-1,500
| -52% | -$41.8K | 0.01% | 537 |
|
|
2017
Q1 | $99.7K | Sell |
2,900
-15,600
| -84% | -$536K | 0.02% | 528 |
|
|
2016
Q4 | $534K | Sell |
18,500
-500
| -3% | -$14.4K | 0.1% | 204 |
|
|
2016
Q3 | $604K | Buy |
19,000
+300
| +2% | +$9.54K | 0.11% | 226 |
|
|
2016
Q2 | $607K | Sell |
18,700
-8,400
| -31% | -$273K | 0.11% | 196 |
|
|
2016
Q1 | $758K | Hold |
27,100
| – | – | 0.14% | 131 |
|
|
2015
Q4 | $966K | Sell |
27,100
-44,200
| -62% | -$1.58M | 0.17% | 115 |
|
|
2015
Q3 | $2.36M | Buy |
71,300
+37,100
| +108% | +$1.23M | 0.31% | 101 |
|
|
2015
Q2 | $1.43M | Hold |
34,200
| – | – | 0.16% | 166 |
|
|
2015
Q1 | $1.11M | Buy |
+34,200
| New | +$1.11M | 0.12% | 187 |
|